Dare Bioscience Inc Earnings

The next earnings date for Dare Bioscience Inc has not yet been scheduled.

Analyst Estimates of Dare Bioscience Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Dare Bioscience Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/05/2025	Before Market	$-0.50	13.79%
03/26/2025	Before Market	---	---
11/07/2024	Before Market	$-0.55	24.66%
08/08/2024	Before Market	$-0.88	-4,500.00%
05/14/2024	Before Market	$-0.07	-16.67%
03/28/2024	Before Market	$-0.06	40.00%
11/09/2023	Before Market	$-0.09	10.00%
08/10/2023	Before Market	$-0.10	0.00%
05/11/2023	Before Market	$-0.09	10.00%
03/30/2023	Before Market	$-0.19	-35.71%
11/10/2022	Before Market	$-0.08	33.33%
08/09/2022	Before Market	$0.00	108.00%
05/12/2022	Before Market	$-0.10	28.57%
03/31/2022	Before Market	$-0.18	-20.00%
11/10/2021	Before Market	$-0.18	-38.46%
08/12/2021	Before Market	$-0.18	-12.50%
05/13/2021	Before Market	$-0.17	22.73%
03/30/2021	Before Market	$-0.28	-115.38%
11/12/2020	Before Market	$-0.24	-41.18%
08/12/2020	Before Market	$-0.27	-80.00%
05/14/2020	Before Market	$-0.18	37.93%
03/27/2020	After Market	$-0.21	-16.67%
11/12/2019	Before Market	$-0.20	4.76%
08/14/2019	After Market	$-0.29	-45.00%
04/01/2019	Before Market	$-0.25	7.41%
03/31/2019	After Market	$-0.25	7.41%
11/13/2018	Before Market	$-0.23	4.17%
08/13/2018	After Market	$-0.32	-39.13%
05/14/2018	After Market	$-0.88	0.00%
03/28/2018	After Market	$-1.48	52.26%
11/13/2017	Before Market	$-0.33	---
08/14/2017	After Market	$-0.20	---
05/12/2017	After Market	$-2.70	12.90%
03/31/2017	Before Market	$-1.60	52.24%
11/03/2016	After Market	$-3.60	11.76%
08/04/2016	After Market	$-4	16.84%
05/02/2016	After Market	$-4.90	-15.02%
03/10/2016	After Market	$-3.90	4.65%
11/16/2015	After Market	$-3.90	5.57%
08/06/2015	After Market	$-3.70	12.94%
05/06/2015	After Market	$-4.10	14.94%
03/19/2015	After Market	$-3.40	30.89%
11/13/2014	After Market	$-2.80	29.47%
08/12/2014	---	$-2.90	19.44%
05/27/2014	---	$-37	-1,145.79%

More About Dare Bioscience Inc

Website

https://darebioscience.com

Country

USA

Full Time Employees

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.

“Dare Bioscience Inc Earnings” Can Refer to the Dare Bioscience Inc Earnings Date

Some people say “Dare Bioscience Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Dare Bioscience Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Dare Bioscience Inc Stock on the Earnings Date

If you own Dare Bioscience Inc stock (DARE) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Dare Bioscience Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Dare Bioscience Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Dare Bioscience Inc Earnings

You can contact us any time if you would like to ask questions about Dare Bioscience Inc earnings or anything else related to the stock market.